These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10964536)

  • 1. Response differences between human CD4(+) and CD8(+) T-cells during CD28 costimulation: implications for immune cell-based therapies and studies related to the expansion of double-positive T-cells during aging.
    Laux I; Khoshnan A; Tindell C; Bae D; Zhu X; June CH; Effros RB; Nel A
    Clin Immunol; 2000 Sep; 96(3):187-97. PubMed ID: 10964536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
    Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
    Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postthymic development of CD28-CD8+ T cell subset: age-associated expansion and shift from memory to naive phenotype.
    Nociari MM; Telford W; Russo C
    J Immunol; 1999 Mar; 162(6):3327-35. PubMed ID: 10092786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
    Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
    Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
    Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
    Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The proliferative response of HIV+ T-cells (CD4+ and CD8+) are severely suppressed via CD28 coactivation.
    Eylar EH; Báez I; Lefranc CE; Colón-Martínez SL; Rodríguez V; Yamamura Y; Rodriguez N
    Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):989-93. PubMed ID: 9449531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The frequency of regulatory CD3+CD8+CD28- CD25+ T lymphocytes in human peripheral blood increases with age.
    Simone R; Zicca A; Saverino D
    J Leukoc Biol; 2008 Dec; 84(6):1454-61. PubMed ID: 18780874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A distinct role for ICOS-mediated co-stimulatory signaling in CD4+ and CD8+ T cell subsets.
    Watanabe M; Hara Y; Tanabe K; Toma H; Abe R
    Int Immunol; 2005 Mar; 17(3):269-78. PubMed ID: 15668466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro stimulation and expansion of human tumour-reactive CD8+ cytotoxic T lymphocytes by anti-CD3/CD28/CD137 magnetic beads.
    Teschner D; Wenzel G; Distler E; Schnürer E; Theobald M; Neurauter AA; Schjetne K; Herr W
    Scand J Immunol; 2011 Aug; 74(2):155-64. PubMed ID: 21517928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-CD28-induced co-stimulation and TCR avidity regulates the differential effect of TGF-beta1 on CD4+ and CD8+ naïve human T-cells.
    Gunnlaugsdottir B; Maggadottir SM; Ludviksson BR
    Int Immunol; 2005 Jan; 17(1):35-44. PubMed ID: 15557315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Processing and release of IL-16 from CD4+ but not CD8+ T cells is activation dependent.
    Wu DM; Zhang Y; Parada NA; Kornfeld H; Nicoll J; Center DM; Cruikshank WW
    J Immunol; 1999 Feb; 162(3):1287-93. PubMed ID: 9973381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential role of lipid rafts in the functions of CD4+ and CD8+ human T lymphocytes with aging.
    Larbi A; Dupuis G; Khalil A; Douziech N; Fortin C; Fülöp T
    Cell Signal; 2006 Jul; 18(7):1017-30. PubMed ID: 16236485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immune system in extreme longevity.
    Sansoni P; Vescovini R; Fagnoni F; Biasini C; Zanni F; Zanlari L; Telera A; Lucchini G; Passeri G; Monti D; Franceschi C; Passeri M
    Exp Gerontol; 2008 Feb; 43(2):61-5. PubMed ID: 17870272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferation and apoptosis of human CD8(+)CD28(+) and CD8(+)CD28(-) lymphocytes during aging.
    Brzezińska A; Magalska A; Szybińska A; Sikora E
    Exp Gerontol; 2004 Apr; 39(4):539-44. PubMed ID: 15050288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.
    Woo EY; Chu CS; Goletz TJ; Schlienger K; Yeh H; Coukos G; Rubin SC; Kaiser LR; June CH
    Cancer Res; 2001 Jun; 61(12):4766-72. PubMed ID: 11406550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulation of CD28 and CTLA-4 expression by CD4 T cells from previously immunodeficient HIV-infected patients with sustained virological responses to highly active antiretroviral therapy.
    Stone SF; Price P; French MA
    HIV Med; 2005 Jul; 6(4):278-83. PubMed ID: 16011533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD28 costimulation overcomes transforming growth factor-beta-mediated repression of proliferation of redirected human CD4+ and CD8+ T cells in an antitumor cell attack.
    Koehler H; Kofler D; Hombach A; Abken H
    Cancer Res; 2007 Mar; 67(5):2265-73. PubMed ID: 17332357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of interleukin-15 on effector and regulatory function of anti-CD3/anti-CD28-stimulated CD4(+) T cells.
    Lin SJ; Cheng PJ; Hsiao SS
    Bone Marrow Transplant; 2006 May; 37(9):881-7. PubMed ID: 16565741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overlap between molecular markers expressed by naturally occurring CD4+CD25+ regulatory T cells and antigen specific CD4+CD25+ and CD8+CD28- T suppressor cells.
    Scotto L; Naiyer AJ; Galluzzo S; Rossi P; Manavalan JS; Kim-Schulze S; Fang J; Favera RD; Cortesini R; Suciu-Foca N
    Hum Immunol; 2004 Nov; 65(11):1297-306. PubMed ID: 15556680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired CD4 and CD8 effector function and decreased memory T cell populations in ICOS-deficient patients.
    Takahashi N; Matsumoto K; Saito H; Nanki T; Miyasaka N; Kobata T; Azuma M; Lee SK; Mizutani S; Morio T
    J Immunol; 2009 May; 182(9):5515-27. PubMed ID: 19380800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.